Neuropeptide Y and neurovascular control in skeletal muscle and skin.
暂无分享,去创建一个
Louis Mattar | Dwayne N Jackson | D. Jackson | J. Shoemaker | G. Hodges | L. Mattar | John M. Johnson | John M Johnson | J Kevin Shoemaker | Gary J Hodges | J. Johnson | John M. Johnson
[1] W. Haefeli,et al. Subconstrictor Doses of Neuropeptide Y Potentiate α1-Adrenergic Venoconstriction In Vivo , 1996 .
[2] D. Larhammar,et al. Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. , 1992, The Journal of biological chemistry.
[3] R. Malmström,et al. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo , 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.
[4] J. Pernow,et al. Evidence for two neuropeptide Y receptors mediating vasoconstriction. , 1991, European journal of pharmacology.
[5] G. Brengelmann,et al. Temperature Regulation in the Neutral Zone , 1997, Annals of the New York Academy of Sciences.
[6] Z. Żukowska-Grójec,et al. Cardiovascular, neuropeptide Y, and adrenergic responses in stress are sexually differentiated , 1991, Physiology & Behavior.
[7] J E Faber,et al. Trophic Effect of Norepinephrine on Arterial Intima-Media and Adventitia Is Augmented by Injury and Mediated by Different &agr;1-Adrenoceptor Subtypes , 2001, Circulation research.
[8] J. Johnson,et al. Selective abolition of adrenergic vasoconstrictor responses in skin by local iontophoresis of bretylium. , 1989, The American journal of physiology.
[9] John M. Johnson,et al. Cardiovascular Adjustments to Heat Stress , 2011 .
[10] J. W. Mcroberts,et al. Carotid artery loop method of blood pressure measurement in the dog. , 1971, Journal of applied physiology.
[11] Z. Żukowska-Grójec,et al. Endogenous neuropeptide Y mediates vasoconstriction during endotoxic and hemorrhagic shock , 1998, Regulatory Peptides.
[12] L. Grundemar. Multiple receptors and multiple actions , 1997 .
[13] M. Heath. Neuropeptide Y and Y1-receptor agonists increase blood flow through arteriovenous anastomoses in rat tail. , 1998, Journal of applied physiology.
[14] C. Wahlestedt,et al. Evidence for different pre- and post-junctional receptors for neuropeptide Y and related peptides , 1986, Regulatory Peptides.
[15] N. Holliday,et al. Neuropeptide Y and Related Peptides , 2004, Handbook of Experimental Pharmacology.
[16] L. Edvinsson,et al. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction by an intracellular calcium-dependent mechanism. , 1993, Journal of the autonomic nervous system.
[17] C. Wahlestedt,et al. Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels , 1984, British journal of pharmacology.
[18] E. Ravussin,et al. Gender differences in muscle sympathetic nerve activity: effect of body fat distribution. , 1996, The American journal of physiology.
[19] J. Lundberg,et al. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y‐Y1 receptor antagonist BIBP 3226 , 1995, British journal of pharmacology.
[20] John M. Johnson,et al. Evidence for a Role for Vasoactive Intestinal Peptide in Active Vasodilatation in the Cutaneous Vasculature of Humans , 2003, The Journal of physiology.
[21] J. Faber,et al. Alpha(1)-adrenoceptor stimulation directly induces growth of vascular wall in vivo. , 2002, American journal of physiology. Heart and circulatory physiology.
[22] R. Marshall,et al. Blood Pressure during Supine Exercise in Idiopathic Orthostatic Hypotension , 1961, Circulation.
[23] K. Hagbarth,et al. Regional similarities and differences in thermoregulatory vaso‐ and sudomotor tone. , 1980, The Journal of physiology.
[24] P. Clifford,et al. Exercise attenuates α-adrenergic-receptor responsiveness in skeletal muscle vasculature , 2001 .
[25] P. Clifford,et al. Neuropeptide Y1 receptor vasoconstriction in exercising canine skeletal muscles. , 2005, Journal of applied physiology.
[26] C. Wahlestedt,et al. The Biology of Neuropeptide Y and Related Peptides , 1993, Contemporary Neuroscience.
[27] C. Y. Chen,et al. Onset of exercise increases lumbar sympathetic nerve activity in rats. , 1996, Medicine and science in sports and exercise.
[28] H. Monyer,et al. Molecular cloning of a novel G protein‐coupled receptor that may belong to the neuropeptide receptor family , 1990, FEBS letters.
[29] J. Shine,et al. Cloned human neuropeptide Y receptor couples to two different second messenger systems. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[30] D. McCloskey,et al. Neuropeptide Y and control of vascular resistance in skeletal muscle , 1988, Regulatory Peptides.
[31] D. A. Williams,et al. Physiologically derived critical evaporative coefficients for protective clothing ensembles. , 1987, Journal of applied physiology.
[32] P. Clifford,et al. Sympathetic vasoconstriction in active skeletal muscles during dynamic exercise. , 1997, Journal of applied physiology.
[33] R. Klabunde. Attenuation of reactive and active hyperemia by sympathetic stimulation in dog gracilis muscle. , 1986, The American journal of physiology.
[34] G. Burnstock,et al. ATP mediates coronary vasoconstriction via P2x-purinoceptors and coronary vasodilatation via P2y-purinoceptors in the isolated perfused rat heart. , 1987, European journal of pharmacology.
[35] Z. Żukowska-Grójec. Neuropeptide Y , 1995, Annals of the New York Academy of Sciences.
[36] T. Hökfelt,et al. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. , 1982, Acta physiologica Scandinavica.
[37] J. Marshall,et al. Contribution of α2-adrenoceptors and Y1 neuropeptide Y receptors to the blunting of sympathetic vasoconstriction induced by systemic hypoxia in the rat , 2007, The Journal of physiology.
[38] C. Wahlestedt,et al. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. , 1985, The Journal of pharmacology and experimental therapeutics.
[39] W. Lautt. Resistance or conductance for expression of arterial vascular tone. , 1989, Microvascular research.
[40] K. Rudolf,et al. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226. , 1995, The Journal of pharmacology and experimental therapeutics.
[41] R. Malmström,et al. Autoinhibitory function of the sympathetic prejunctional neuropeptide Y Y(2) receptor evidenced by BIIE0246. , 2002, European journal of pharmacology.
[42] D. Jackson,et al. Neuropeptide Y bioavailability is suppressed in the hindlimb of female Sprague‐Dawley rats , 2005, The Journal of physiology.
[43] T. Hökfelt,et al. Neuropeptide Y: presence in perivascular noradrenergic neurons and vasoconstrictor effects on skeletal muscle blood vessels in experimental animals and man , 1987, Regulatory Peptides.
[44] J. Angus,et al. The alpha adrenoceptors on endothelial cells. , 1986, Federation proceedings.
[45] G. Liu,et al. The signal transduction pathway causing the synergistic hypertrophic effects of neuropeptide Y and norepinephrine on primary cardiomyocyte , 2001, Neuropeptides.
[46] P. Clifford,et al. The Paradox of Sympathetic Vasoconstriction in Exercising Skeletal Muscle , 2001, Exercise and sport sciences reviews.
[47] R. Quirion,et al. Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[48] Seymour Reichlin,et al. Handbook of experimental pharmacology , 1984 .
[49] Z. Żukowska-Grójec,et al. Role of neuropeptide Y (NPY) in cardiovascular responses to stress , 1988, Synapse.
[50] Z. Żukowska-Grójec,et al. Neuropeptide Y: an adrenergic cotransmitter, vasoconstrictor, and a nerve-derived vascular growth factor. , 1998, Advances in pharmacology.
[51] R. Malmström. Existence of both neuropeptide Y, Y1 and Y2 receptors in pig spleen: evidence using subtype-selective antagonists in vivo. , 2001, Life sciences.
[52] V. Miller,et al. Alpha 2-adrenoceptors and endothelium-derived relaxing factor. , 1989, The American journal of medicine.
[53] H. Herzog,et al. The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors , 2003, British journal of pharmacology.
[54] P. Clifford,et al. Sympathetic restraint of muscle blood flow at the onset of dynamic exercise. , 2002, Journal of applied physiology.
[55] F. Sundler,et al. FP, PYY, and NPY: Occurrence and Distribution in the Periphery , 1993 .
[56] C. Adreani,et al. Muscle reflex stimulates sympathetic postganglionic efferents innervating triceps surae muscles of cats. , 1996, The American journal of physiology.
[57] J. Kitlinska,et al. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system. , 2003, Canadian journal of physiology and pharmacology.
[58] P. Clifford,et al. α-Adrenergic vasoconstriction in active skeletal muscles during dynamic exercise. , 1999, American journal of physiology. Heart and circulatory physiology.
[59] P. Clifford,et al. Vasoconstriction in active skeletal muscles: a potential role for P2X purinergic receptors? , 2003, Journal of applied physiology.
[60] C. Wahlestedt,et al. Origin and Actions of Neuropeptide Y in the Cardiovascular System , 1993 .
[61] V. Miller,et al. Alpha2-adrenoceptors and endothelium-derived relaxing factor , 1989 .
[62] J. Mitchell,et al. Functional Sympatholysis During Muscular Activity: OBSERVATIONS ON INFLUENCE OF CAROTID SINUS ON OXYGEN UPTAKE , 1962, Circulation research.
[63] J. Johnson,et al. Nonnoradrenergic mechanism of reflex cutaneous vasoconstriction in men. , 2001, American journal of physiology. Heart and circulatory physiology.
[64] D. O'Leary,et al. Integrative control of the skeletal muscle microcirculation in the maintenance of arterial pressure during exercise. , 2004, Journal of applied physiology.
[65] D. Erlinge,et al. Forearm blood flow responses to neuropeptide Y, noradrenaline and adenosine 5'-triphosphate in hypertensive and normotensive subjects. , 2000, Blood pressure.
[66] A. Ng,et al. Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. , 1993, Hypertension.
[67] D. Erlinge,et al. Contractile effects of neuropeptide Y in human subcutaneous resistance arteries are mediated by Y1 receptors. , 1996, Journal of cardiovascular pharmacology.
[68] W. Rascher,et al. Neuropeptide Y: a possible role in hypertension? , 1995, Journal of hypertension.
[69] N. Charkoudian,et al. Sympathetic nonnoradrenergic cutaneous vasoconstriction in women is associated with reproductive hormone status. , 2002, American journal of physiology. Heart and circulatory physiology.
[70] D. Erlinge,et al. In vivo receptor characterization of neuropeptide Y‐induced effects in consecutive vascular sections of cat skeletal muscle , 1997, British journal of pharmacology.
[71] P. Hjemdahl,et al. Co-release of neuropeptide Y and catecholamines during physical exercise in man. , 1985, Biochemical and biophysical research communications.
[72] T. Pedrazzini,et al. Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor , 1998, Nature Medicine.
[73] Long Dm,et al. Carotid artery loop for repeated catheterization of the left ventricle in dogs. , 1971 .
[74] G. Grassi,et al. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. , 1999, Hypertension.
[75] J. Angus,et al. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin , 1983, Nature.
[76] Y. Shigeri,et al. Neuropeptide Y stimulates DNA synthesis in vascular smooth muscle cells , 1993, Neuroscience Letters.
[77] D. Reis,et al. Neuropeptide Y Receptor Subtypes, Y1 and Y2 , 1990, Annals of the New York Academy of Sciences.
[78] P. Clifford,et al. Effect of dynamic exercise on renal sympathetic nerve activity in conscious rabbits. , 1993, Journal of applied physiology.
[79] John M. Johnson,et al. Sympathetic, sensory, and nonneuronal contributions to the cutaneous vasoconstrictor response to local cooling. , 2005, American journal of physiology. Heart and circulatory physiology.
[80] G. Hodges,et al. The involvement of norepinephrine, neuropeptide Y, and nitric oxide in the cutaneous vasodilator response to local heating in humans. , 2008, Journal of applied physiology.
[81] W. Haefeli,et al. Human neuropeptide Y potentiates α1-adrenergic blood pressure responses in vivo. , 1998, American journal of physiology. Heart and circulatory physiology.
[82] T. Branchek,et al. Expression Cloning and Pharmacological Characterization of a Human Hippocampal Neuropeptide Y/Peptide YY Y2 Receptor Subtype (*) , 1995, The Journal of Biological Chemistry.
[83] D. Kimmerly,et al. Gender affects sympathetic and hemodynamic response to postural stress. , 2001, American journal of physiology. Heart and circulatory physiology.
[84] M. Joyner,et al. α1- and α2-adrenergic vasoconstriction is blunted in contracting human muscle , 2003 .
[85] Daniel Grandt,et al. Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV , 1993, Regulatory Peptides.
[86] V. Mutt,et al. Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide , 1982, Nature.
[87] B. Saltin,et al. Maximal perfusion of skeletal muscle in man. , 1985, The Journal of physiology.
[88] M. Statnick,et al. Characterization of the neuropeptide Y5 receptor in the human hypothalamus: a lack of correlation between Y5 mRNA levels and binding sites , 1998, Brain Research.
[89] J. Lundberg,et al. Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade. , 1982, Acta physiologica Scandinavica.
[90] W. De Potter,et al. Noradrenaline Storing Vesicles in Sympathetic Neurons and Their Putative Role in Neurotransmitter Release: An Historical Overview of Controversial Issues , 1997, Neurochemical Research.
[91] P. De Camilli,et al. Pathways to regulated exocytosis in neurons. , 1990, Annual review of physiology.
[92] P. Hjemdahl,et al. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. , 2008, Clinical physiology.
[93] D. Seals,et al. Age-associated arterial wall thickening is related to elevations in sympathetic activity in healthy humans. , 2000, American journal of physiology. Heart and circulatory physiology.
[94] D. Jackson,et al. Gender‐modulated endogenous baseline neuropeptide Y Y1‐receptor activation in the hindlimb of Sprague‐Dawley rats , 2005, The Journal of physiology.
[95] A. Pessina,et al. Sympathetic drive and vascular damage in hypertension and atherosclerosis. , 1991, Hypertension.
[96] G. Schnorrenberg,et al. BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist. , 1999, European journal of pharmacology.
[97] L. Rowell. Human Cardiovascular Control , 1993 .
[98] E. Coen,et al. Evidence against differential release of noradrenaline, neuropeptide Y, and dopamine‐β‐hydroxylase from adrenergic nerves in the isolated perfused sheep spleen , 1995, Synapse.
[99] W. E. Glover. INCREASED SENSITIVITY OF RABBIT EAR ARTERY TO NORADRENALINE FOLLOWING PERIVASCULAR NERVE STIMULATION MAY BE A RESPONSE TO NEUROPEPTIDE Y RELEASED AS COTRANSMITTER , 1985, Clinical and experimental pharmacology & physiology.
[100] G. Jennings,et al. Adverse consequences of high sympathetic nervous activity in the failing human heart. , 1995, Journal of the American College of Cardiology.
[101] T. Glenn,et al. Vascular responses to neuropeptide Y are greater in female than male rats , 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.
[102] T. Hedner,et al. Does the neuropeptide Y Y1 receptor contribute to blood pressure control in the spontaneously hypertensive rat? , 1997, Journal of hypertension.
[103] M. Michel,et al. Gender and hypertension interact to regulate neuropeptide Y receptor responsiveness , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.
[104] S. Sabol,et al. Rat neuropeptide Y precursor gene expression. mRNA structure, tissue distribution, and regulation by glucocorticoids, cyclic AMP, and phorbol ester. , 1988, The Journal of biological chemistry.
[105] A. Beck‐Sickinger,et al. The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226. , 1994, European journal of pharmacology.
[106] J. Huidobro-Toro,et al. Neuropeptide Y-induced pressor responses: activation of a non-adrenergic mechanism, potentiation by reserpine and blockade by nifedipine. , 1985, European journal of pharmacology.
[107] L. Edvinsson,et al. Neuropeptide Y Y1 and neuropeptide Y Y2 receptors in human cardiovascular tissues , 2002, Peptides.
[108] G. Fisone,et al. Regulation of the release of coexisting neurotransmitters. , 1988, Annual review of pharmacology and toxicology.
[109] J. Lundberg. Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. , 1996, Pharmacological reviews.
[110] G. Grassi,et al. Cardiovascular risk and adrenergic overdrive in the metabolic syndrome. , 2007, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[111] A. Franco‐Cereceda,et al. Differential release of classical transmitters and peptides. , 1994, Advances in second messenger and phosphoprotein research.
[112] F. Yamazaki,et al. Rate dependency and role of nitric oxide in the vascular response to direct cooling in human skin. , 2006, Journal of applied physiology.
[113] K. Matsukawa,et al. Anesthetic effects on tonic and reflex renal sympathetic nerve activity in awake cats. , 1989, The American journal of physiology.
[114] G. Hodges,et al. The involvement of nitric oxide in the cutaneous vasoconstrictor response to local cooling in humans , 2006, The Journal of physiology.
[115] J. Lundberg,et al. Neuropeptide Y (NPY): enhancement of blood pressure increase upon alpha-adrenoceptor activation and direct pressor effects in pithed rats. , 1985, European journal of pharmacology.
[116] M. Joyner,et al. Is sympathetic neural vasoconstriction blunted in the vascular bed of exercising human muscle? , 2002, The Journal of physiology.
[117] E. Potter,et al. Effects of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246, on Y2 receptors at peripheral neuroeffector junctions , 2001, British journal of pharmacology.
[118] C. Wahlestedt,et al. Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers , 1984, Regulatory Peptides.
[119] P. Clifford,et al. Do P2X purinergic receptors regulate skeletal muscle blood flow during exercise? , 2004, American journal of physiology. Heart and circulatory physiology.
[120] G. Burnstock,et al. Direct evidence for concomitant release of noradrenaline, adenosine 5'-triphosphate and neuropeptide Y from sympathetic nerve supplying the guinea-pig vas deferens. , 1988, Journal of the autonomic nervous system.
[121] H. Matsubayashi,et al. Compensatory vasoconstrictor effects of sodium pentobarbital on the hindquarters of conscious normotensive control and lumbar-sympathectomized Wistar rats , 2000, Autonomic Neuroscience.
[122] Lydia E. Kuo,et al. Stress, NPY and vascular remodeling: Implications for stress-related diseases , 2007, Peptides.
[123] W. Rascher,et al. Regulation of NPY/NPY Y1 receptor/G protein system in rat brain cortex. , 1995, The American journal of physiology.
[124] J. Dixon,et al. Cloning, characterization, and DNA sequence of a human cDNA encoding neuropeptide tyrosine. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[125] S. Bloom,et al. Neuropeptide Y and drug development , 1997 .
[126] J. Chalmers,et al. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man. , 1986, Journal of the autonomic nervous system.
[127] G. Burnstock,et al. The contributions of noradrenaline and ATP to the responses of the rabbit central ear artery to sympathetic nerve stimulation depend on the parameters of stimulation. , 1986, European journal of pharmacology.
[128] R. Malmström. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control. , 1997, Acta physiologica Scandinavica. Supplementum.
[129] A. Schoups,et al. Noradrenergic neurons release both noradrenaline and neuropeptide Y from a single pool: The large dense cored vesicles , 1997, Synapse.
[130] Caitlin Thompson,et al. Altered neurotransmitter control of reflex vasoconstriction in aged human skin , 2004, The Journal of physiology.
[131] J. L. Morris. Selective constriction of small cutaneous arteries by NPY matches distribution of NPY in sympathetic axons , 1994, Regulatory Peptides.
[132] C. S. Gal,et al. The cloned guinea pig neuropeptide Y receptor Y1 conforms to other mammalian Y1 receptors , 1999, Peptides.
[133] Jia-Yi Li,et al. Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats , 2006, British journal of pharmacology.
[134] R. Kelly. Storage and release of neurotransmitters , 1993, Cell.
[135] D L Kellogg,et al. Cutaneous active vasodilation in humans is mediated by cholinergic nerve cotransmission. , 1995, Circulation research.
[136] M. Lapiński,et al. Plasma neuropeptide Y and catecholamines in women and men with essential hypertension. , 1995, Blood pressure.
[137] P. Hjemdahl,et al. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle. , 1988, Acta physiologica Scandinavica.
[138] John M. Johnson,et al. Neuropeptide Y antagonism reduces reflex cutaneous vasoconstriction in humans. , 2004, American journal of physiology. Heart and circulatory physiology.
[139] A. Mark,et al. Central command increases sympathetic nerve activity during spontaneous locomotion in cats. , 1991, Circulation research.
[140] A. Franco‐Cereceda,et al. Neuropeptide Y Y1 receptors in vascular pharmacology. , 1998, European journal of pharmacology.
[141] R. Armstrong,et al. Progressive elevations in muscle blood flow during prolonged exercise in swine. , 1987, Journal of applied physiology.
[142] T. Hökfelt,et al. Characterization and molecular cloning of vascular neuropeptide Y receptor subtypes in pig and dog , 1998, Regulatory Peptides.
[143] A. Franco‐Cereceda,et al. Neuropeptide Y and Sympathetic Neurotransmission a , 1990, Annals of the New York Academy of Sciences.
[144] T. Hedner,et al. Neuropeptide Y potentiates noradrenaline-induced contraction through the neuropeptide Y Y1 receptor. , 1996, European journal of pharmacology.
[145] D. Jackson,et al. Y1- and α1-receptor control of basal hindlimb vascular tone , 2004 .
[146] C. D. Johnson,et al. Effects of varying impulse number on cotransmitter contributions to sympathetic vasoconstriction in rat tail artery. , 2003, American journal of physiology. Heart and circulatory physiology.
[147] P. Clifford,et al. Skeletal muscle vasodilation at the onset of exercise. , 1998, Journal of applied physiology.